Systematic Evaluation of Solid Phase Extraction (SPE) Chemistries for the Determination of Acidic, Neutral, and Basic Drugs

Similar documents
SPE Method Development for Pharmaceutical Bioanalysis

Using Hydrophilic Interaction Chromatography (HILIC) for the Retention of Highly Polar Analytes

Comprehensive Study of SLE as a Sample. Preparation Tool for Bioanalysis

Enrichment of Phospholipids from Biological Matrices with Zirconium Oxide-Modified Silica Sorbents

Performance of an ultra low elution volume 96-well plate

Analytical and Preparative SFC Columns

Simultaneous Quantitative Analysis of Total Catecholamines and Metanephrines in Urine Using CLEAN UP CCX2 and LC-MS/MS

Impact of Reversed-Phase Chiral Chromatography on the LC-MS Analysis of Drugs in Biological Fluids

Analysis of HMF by HPLC

Removal of Triton X-100 from Plasma Samples Using Mixed-Mode Solid Phase Extraction (SPE)

Simultaneous Quantitative Analysis of Total Catecholamines and Metanephrines in Urine Using 500 MG CLEAN UP CCX2 and LC-MS/MS

Alternative Method of Hybrid SPE Sample Preparation for High Recovery LC-MS Analysis of Pharmaceutical Compounds in Plasma

Taking the Complexity out of SPE Method Development

Fortis Method Development Options

Sepax Technologies, Inc.

Unique Retention and Selectivity of Pentafluorophenylpropyl Phases for High-Throughput LC/MS Analysis

Separation of Macrocyclic Lactones (Avermectins) on FLARE C18 MM & FLARE C18+ Columns

Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry

High Throughput Extraction of Opiates from Urine and Analysis by GC/MS or LC/MS/MS)

Detection of Low Level of Chloramphenicol in Milk and Honey with MIP SPE and LC-MS-MS

Strata -X Polymeric SPE

Extraction of Aflatoxin M1 From Infant Formula Using ISOLUTE Myco SPE Columns prior to LC-MS/MS Analysis

Application Note. Abstract. Authors. Pharmaceutical

Separation of Vitamin D and Vitamin D Metabolites on FLARE C18 MM (Mixed Mode) HPLC Column

Robust extraction, separation, and quantitation of structural isomer steroids from human plasma by SPE-UHPLC-MS/MS

Eurospher II the logical choice. Physical properties of Eurospher II silica gel: Silica gel: ultra pure, > % Metal content: < 10 ppm

Simplifying Solid-Phase Extraction [ OASIS SOLID-PHASE EXTRACTION PRODUCTS ]

Ion Exchange and Reversed Phase interactions in selective Bio-SPME extractions of designer drugs

The Development of LC/MS Methods for Determination of MDMA (Ecstasy) and Metabolites in Biological Samples

Identification and Quantification of Psychedelic Phenethylamine 2C Series using SPE and LC-MS/MS

The LC Column Playbook

Agilent Technologies Prep LC Columns

Extraction of Multiple Mycotoxins From Nuts Using ISOLUTE Myco prior to LC-MS/MS Analysis

Rapid and Robust Detection of THC and Its Metabolites in Blood

SPE Cartridges. All Finneran Products Are Certified. Conditioning Sample application Wash Elution

SOLID PHASE EXTRACTION: Fundamentals and Recent Developments

IAM Chromatography. Introduction

HPLC Analysis of Sugars

The Development of LC/MS Methods for Determination of Polar Drugs of Abuse in Biological Samples

A New HILIC/RP Mixed-Mode Column and Its Applications in Surfactant Analysis

YMC HILIC Columns for Polar Analytes

Restek Ultra II HPLC Columns

SPME-LC Fibers for a Variety of Applications

Simultaneous Analysis of Intact Human Insulin and Five Analogs in Human Plasma Using μelution SPE and a CORTECS UPLC Column

Analysis of short chain organic acids in tobacco and in some flavored e-liquids

Extraction of Multiple Mycotoxins From Grain Using ISOLUTE Myco prior to LC-MS/MS Analysis

The Raptor HILIC-Si Column

Ultra Columns. also available. ordering note

Ultra Columns HPLC COLUMNS

Comparison of a UPLC Method across Multiple UHPLC Systems

Authors. Abstract. Forensic Toxicology. Irina Dioumaeva, John M. Hughes Agilent Technologies, Inc.

CHAPTER-2. Table of Contents. S.No. Name of the Sub-Title Page No. 2.1 Literature survey for simultaneous estimation of selected drugs by RP-HPLC

APPLICATIONS TN A Comparison of Various Kinetex C18 Phases USP: L1

SeQuant ZIC -HILIC For all who expect more...

Shuguang Li, Jason Anspach, Sky Countryman, and Erica Pike Phenomenex, Inc., 411 Madrid Ave., Torrance, CA USA PO _W

Development of a Bioanalytical Method for Quantification of Amyloid Beta Peptides in Cerebrospinal Fluid

Determination of Tetracyclines in Chicken by Solid-Phase Extraction and High-Performance Liquid Chromatography

Rapid and sensitive UHPLC screening of additives in carbonated beverages with a robust organic acid column

The challenging extraction of non-polar contaminants out of a non-polar vegetable oil sample

Extraction of Synthetic and Naturally Occurring Cannabinoids in Urine Using SPE and LC-MS/MS

Dr. Erin E. Chambers Waters Corporation. Presented by Dr. Diego Rodriguez Cabaleiro Waters Europe Waters Corporation 1

SPE and QuEChERS Method Development. Tina Chambers Christophe Deckers lent.com

Rapid and sensitive UHPLC screening for water soluble vitamins in sports beverages

Dienes Derivatization MaxSpec Kit

Utility of Pentafluorophenylpropyl Stationary Phases for RP-HPLC Analyses: Biogenic Amines on Discovery HS F5

InertSustain Phenylhexyl. A New Second Choice Column to Change Chromatographic Behavior

Protein Precipitation for Biological Fluid Samples Using Agilent Captiva EMR Lipid 96-Well Plates

SeQuant ZIC -HILIC For all who expect more...

A RAPID AND SENSITIVE UPLC/UV/MS METHOD FOR SIMVASTATIN AND LOVA S TAT IN IN SU P P O RT O F C L E A NING VA L I DAT IO N S T U DIES

HxSil C18, 4.6 x 150mm, 5um (P/N 79868) 1. Oxybenzone 2. Octocrylene 3. Octyl Methoxycinnamate 4. Avobenzone (Parsol 1789) 5.

Simultaneous Analysis of Active Pharmaceutical Ingredients and Their Counter-Ions Using a Mixed-Mode Column

Studies on Stationary Phase Selectivity for Solid-Core Particles

Application Note. Author. Abstract. Introduction. Food Safety

Extraction of a Comprehensive Steroid Panel from Human Serum Using ISOLUTE. SLE+ Prior to LC/MS-MS Analysis

Vitamin D Metabolite Analysis in Biological Samples Using Agilent Captiva EMR Lipid

Overcoming the Challenges of Sample Preparation and LC/MS/MS Method Development for Clinical Applications

The HPLC Preparative Scale-Up of Soybean Phospholipids Application

Achiral SFC: Development of an Orthogonal SFC Method for Mometasone Furoate Impurity Analysis

Transfer and Speed-up of Methods to Fused-Core Particle Columns EPA Method 1694

Authors. Abstract. Introduction. Environmental

Fig. 1: Chemical structure of arachidonic acid COOH CH 3

GlycanPac AXH-1 Columns

Table S1b. TLC conditions for each drug (standard or in milk matrix) tested.

LC/MS Analysis of Various Hydrophilic Compounds Using a Polymer-Based Amino Column - Shodex TM HILICpak TM VG-50 2D

Mass-Based Purification of Natural Product Impurities Using an Agilent 1260 Infinity II Preparative LC/MSD System

Determination of Patulin in Apple Juice Using SPE and UHPLC-MS/MS Analysis

LC-MS/MS analysis of Chlorates in Milk and Whey Powder using the Agilent 6470 QQQ

HPLC Separation Tools for Membrane Protein Purification and Drug Membrane Permeability Prediction

USP Method Transfer of Ziprasidone HCl from HPLC to UPLC

14 Separation of the Phosphatidylcholines Using Reverse Phase HPLC

LC-MS/MS Method for the Determination of Tenofovir from Plasma

The Ephedra Story: An Automated SPE Procedure and Analysis for the Determination of Ephedra and Ephedra-like Compounds in Dietary Supplements

Impurity Profiling of Carbamazepine by HPLC/UV

Ke He 1, Anne Timm 2, and Lee Blaney 1. University of Maryland Baltimore County. US Department of Agriculture Forest Service

A Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS

Reduced Ion Suppression and Improved LC/MS Sensitivity with Agilent Bond Elut Plexa

Institute of Toxicology Clinical Toxicology and Pharmacology Berliner Betrieb für Zentrale Gesundheitliche Aufgaben, Berlin

Efficient Quantitative Analysis of THC and Metabolites in Human Plasma Using Agilent Captiva EMR Lipid and LC-MS/MS

Transcription:

Systematic Evaluation of Solid Phase Extraction (SPE) Chemistries for the Determination of Acidic, Neutral, and Basic Drugs Laura Marlatt, An Trinh, and David S. Bell Supelco, 595 North Harrison Road, Bellefonte, PA 16823 T404049 GUX

Abstract Solid phase extraction is one of the most widely used tools for sample cleanup. Because it is believed that method development for solid phase extraction is overly time consuming, many scientists choose to follow a generic method using universal supports, such as the most popular phase chemistry, C18. The aim of this study is to explore the differences in various phase chemistries, then utilize their specificity in solid phase extraction. SPE methods were systematically developed for acid, neutral and basic drugs to recognize other phase chemistries that are often overlooked. Three different phase chemistries were utilized. Through methodic wash/elute profiles, advantages and disadvantages of the different phase chemistries were established for a particular sample and matrix. Strategies for improving SPE method development are discussed. The compounds studied were alprenolol, diphenhydramine, hydrocortisone, ibuprofen, nalidixic acid, naproxen and nortriptyline. The derivatives were analyzed by HPLC.

Introduction SPE methods are frequently developed by copying or modifying an existing application or choosing a generic method. Although these approaches are less time-consuming, they often result in sub-optimal recovery/reproducibility and poor selectivity/sample clean up. As a result, it can often be very difficult to determine the root cause(s) of a specific problem(s) associated with an SPE method. Some examples include: Poor Recovery. Is it due to Poor retention during sample load? Pre-mature elution during wash? Over retention during elution? Poor Reproducibility. Typically caused by one or more inadequate steps. Which one? Insufficient clean-up. Stronger wash solvent? Maybe a different SPE phase?

Introduction (contd.) For sample prep methods intended for extensive use (e.g., preclinical and clinical studies), extra effort in SPE method development can save costly reanalysis, redevelopment, and revalidation time. In this study, 7 representative pharmaceutical compounds (3 basic, 3 acidic, and 1 neutral) were extracted on three different SPE chemistries: C18, C8, and CN followed by HPLC-UV analysis. Using standards and buffered/organically modified solutions, key variables (ph and percent organic modifier) affecting analyte retention and elution were systematically profiled to determine analyte behavior relative to changing extraction conditions. By approaching method development systematically, application specific data was generated for more effective method development, optimization, and troubleshooting.

Experimental- Approach Systematic SPE Method Development Step 1 - Load Optimization 1. Develop analytical method (Figure A) 2. Screen SPE phases for loadability (compound retention) 3. Analyze load flow-thru for premature compound breakthrough Step 2 - Establish Optimal Wash and Elution Solvents 1. Load samples according to step 1 2. Systematically profile wash/elute solvents of varying ph and percent organic modifier 3. Analyze for recovery and plot results Step 3 - Evaluation 1. Determine analyte(s) behavior on sorbent(s) in response to changing extraction conditions 2. Define method, incorporate sample matrix, and optimize/ troubleshoot as necessary

The SPE Process Phase & Hardware Selection Condition/ Equilibrate Load Sample Wash Off Co-Extracted Interferences Elute Analytes

Figure A. Example Chromatogram of Standard Test Mix Column: Discovery HS C18, 5cm x 4.6mm ID, 3µm particles Mobile Phase: (A) 20mM potassium phosphate, ph 2.8; (B) acetonitrile Flow Rate: 1.0mL/min Temperature: 35 C Detection: UV, 220nm Injection: 20µL 1. Alprenolol 2. Hydrocortisone Min %A %B 6 3. Diphenhydramine 0 65 35 4. Nalidixic acid 3 65 35 12 35 65 15 35 65 20 35 65 4 5. Nortriptyline 6. Naproxen 7. Ibuprofen 1 2 3 5 7 0 2 4 6 8 10 12 14 16 18 Time (min)

Load Optimization SPE: Discovery DSC-18 96-Well SPE (100mg/well) Discovery DSC-8 96-Well SPE (100mg/well) Discovery DSC-CN 96-Well SPE (100mg/well) 1. Prepare standard test mix containing all 7 compounds (20µg/mL spike level) in 20mM potassium phosphate, ph 3 (low ph), ph 7 (neutral ph), and ph 10 (high ph) 2. Condition & equilibrate SPE wells (C18, C8, & CN) with 2mL methanol & DI H 2 O 3. Load 1mL of each standard test mix (low, neutral, and high ph) 4. Collect load flow-through eluate & analyze for compound breakthrough via HPLC-UV (see results)

Wash/Elute Profile SPE: Discovery DSC-18 96-well SPE (100mg/well) Discovery DSC-8 96-well SPE (100mg/well) Discovery DSC-CN 96-well SPE (100mg/well) 1. Condition & equilibrate SPE wells (C18, C8, & CN) with 2mL methanol & DI H 2 O 2. Load 1mL of the 20µg/mL standard test mix, ph 7 (neutral ph) 3. Wash/elute respective wells with 1mL test solvents ranging from 0-100% methanol in 2% NH 4 OH, ph 11 (high ph), DI H 2 O (neutral ph), and 2% CH 3 COOH, ph 3 (low ph) 4. Collect wash/elute eluate & analyze for compound breakthrough via HPLC-UV (see results)

Results Load Optimization Adequate retention was observed for each of the 7 analytes tested on all three SPE chemistries (C18, C8, & CN) Load retention determined by analyzing load flow-through eluate for compound breakthrough via HPLC-UV Shift in load ph (b/w 3-11) did not affect retention during sample load A sample load ph of 7 was chosen for all subsequent studies Wash/Elute Profiles Standard test mix samples were loaded onto C18, C8, & CN SPE wells, and eluted with test solvents ranging from 0-100% methanol in 2% acetic acid (low ph), DI water (neutral ph), & 2% NH4OH (high ph). Figure B explains the important role of ph in reversed-phase SPE The data is organized and visually depicted (Figures C-E)

Figure B. The Critical Role of ph in SPE Ionization of Acidic & Basic Molecules- Acids (e.g., carboxylic acids): HA H + + A - (e.g., R-COOH! R-COO - ) (Un-ionized) (ionized) 50% @pka 50% 100% low ph 0% 0% high ph 100% Neutral State (Blue) = promotes hydrophobic (reversed-phase) Bases (e.g., amines): interaction b/w compound and sorbent BH + + OH - B (e.g., R-NH 3+! R-NH 2 ) (Ionized) (Un-ionized) 50% @pka 50% 100% low ph 0% 0% high ph 100%

Figure C. Wash/Elute Profile Basic Compounds Alprenolol % MeOH in 2% CH3COOH % MeOH in DI H2O % MeOH in 2% NH4OH 140.0 120.0 DSC-18 SPE DSC-8 SPE DSC-CN SPE Recovery (%) 100.0 80.0 60.0 40.0 20.0 0.0 0 5 10 20 40 60 80 100 0 5 10 20 40 60 80 100 0 5 10 20 40 60 80 100 % MeOH

Figure C (contd.) Diphenhydramine % MeOH in 2% CH3COOH % MeOH in DI H2O % MeOH in 2% NH4OH 140.0 120.0 DSC-18 SPE DSC-8 SPE DSC-CN SPE Recovery (%) 100.0 80.0 60.0 40.0 20.0 0.0 0 5 10 20 40 60 80 100 0 5 10 20 40 60 80 100 0 5 10 20 40 60 80 100 % MeOH

Figure C (contd.) Nortriptyline % MeOH in 2% CH3COOH % MeOH in DI H2O % MeOH in 2% NH4OH 140.0 120.0 DSC-18 SPE DSC-8 SPE DSC-CN SPE Recovery (%) 100.0 80.0 60.0 40.0 20.0 0.0 0 5 10 20 40 60 80 100 0 5 10 20 40 60 80 100 0 5 10 20 40 60 80 100 % MeOH

Wash/Elute Profile - Basic Compounds (Fig. C) High ph conditions (%MeOH in 2% NH 4 OH) Basic compounds in their neutral form More strongly retained under reversed-phase conditions Stronger solvents can be used during the wash step to improve selectivity Up to 60% MeOH can be used as a potential wash solvent on C18 and C8 SPE before premature elution occurs, and 20% MeOH for CN SPE Low ph conditions (%MeOH in CH 3 COOH) Basic compounds in their ionized form Ionized form weakens reversed-phase retention Weaker solvents must be used during wash step Maximum wash strength of 20% MeOH is allowable before premature elution occurs Weaker elution solvents may be possible (e.g. 60% MeOH) under low ph conditions improving selectivity and/or allowing for direct-inject protocols (no eluate evaporation/reconstitution)

Wash/Elute Profile - Basic Compounds (contd.) Neutral ph conditions (%MeOH in DI H 2 O) None of the basic compounds eluted on CN SPE CN (cyanopropyl) SPE s short alkyl chain exposed more silanol groups on the silica sorbent s surface. The silanol groups acted like weak cation-exchangers. Basic compounds retained via mixed-mode behavior when processed at neutral ph on CN SPE At high and low ph, basic compounds and silanol groups are neutralized, respectively, disrupting secondary ion-exchange behavior Using secondary silanol interactions, researchers can potentially maximize sample clean-up on DSC-CN by first washing with 80% methanol and then eluting with acidified methanol.

Potential Reversed-Phase Protocols for Basic Compounds DSC-18 SPE 1. Condition/equilibrate with MeOH & DI water 2. Load sample at ph 7 3. Wash with 60% MeOH in 2% NH 4 OH 4. Elute with 100% CH 3 COOH in MeOH DSC-8 SPE 1. Condition/equilibrate with MeOH & DI water 2. Load sample at ph 7 3. Wash with 60% MeOH in 2% NH 4 OH 4. Elute with 80-100% MeOH in CH 3 COOH DSC-CN SPE 1. Condition/equilibrate with MeOH & DI water 2. Load sample at ph 7 3. Wash with 80% MeOH 4. Elute with 80-100% MeOH in CH 3 COOH

Figure D. Wash/Elute Profile Acidic Compounds Ibuprofen % MeOH in 2% CH3COOH % MeOH in DI H2O % MeOH in 2% NH4OH 140.0 120.0 DSC-18 SPE DSC-8 SPE DSC-CN SPE Recovery (%) 100.0 80.0 60.0 40.0 20.0 0.0 0 5 10 20 40 60 80 100 0 5 10 20 40 60 80 100 0 5 10 20 40 60 80 100 % MeOH

Figure D (contd.) Nalidixic Acid % MeOH in 2% CH3COOH % MeOH in DI H2O % MeOH in 2% NH4OH 140.0 120.0 DSC-18 SPE DSC-8 SPE DSC-CN SPE Recovery (%) 100.0 80.0 60.0 40.0 20.0 0.0 0 5 10 20 40 60 80 100 0 5 10 20 40 60 80 100 0 5 10 20 40 60 80 100 % MeOH

Figure D (contd.) Naproxen % MeOH in 2% CH3COOH % MeOH in DI H2O % MeOH in 2% NH4OH 140.0 120.0 DSC-18 SPE DSC-8 SPE DSC-CN SPE Recovery (%) 100.0 80.0 60.0 40.0 20.0 0.0 0 5 10 20 40 60 80 100 0 5 10 20 40 60 80 100 0 5 10 20 40 60 80 100 % MeOH

Wash/Elute Profile - Acidic Compounds (Fig. D) Low ph conditions (%MeOH in 2% CH 3 COOH) Acidic compounds in their neutral form More strongly retained under reversed-phase conditions Stronger solvents can be used during the wash step to improve selectivity Up to 40% MeOH can be used as a potential wash solvent on C18 & C8 SPE for naproxen & ibuprofen before premature elution occurs. High ph and neutral conditions (%MeOH in NH 4 OH and DI H 2 O) Acidic compounds in their ionized form Ionized form weakens reversed-phase retention resulting in very poor retention on all three SPE chemistries Most of the acidic compounds tested began eluting at very low solvent strengths (0-5% MeOH). This effect was most pronounced on less hydrophobic phases such as CN SPE. Weaker elution solvents may be possible (e.g. 40-60% MeOH) under high/neutral ph conditions improving selectivity and/or allowing for direct-inject protocols (no eluate evaporation/reconstitution).

Potential Reversed-Phase Protocols for Acidic Compounds DSC-18 SPE 1. Condition/equilibrate with MeOH & DI water 2. Load sample at ph 7 3. Wash with 20% MeOH in 2% CH 3 COOH 4. Elute with 100% MeOH DSC-8 SPE 1. Condition/equilibrate with MeOH & DI water 2. Load sample at ph 7 3. Wash with 20% MeOH in 2% CH 3 COOH 4. Elute with 100% MeOH DSC-CN SPE 1. Condition/equilibrate with MeOH & DI water 2. Load sample at ph 7 3. Wash with 20% MeOH in 2% CH 3 COOH 4. Elute with 100% MeOH

Figure E. Wash/Elute Profile Neutral Compounds Hydrocortisone % MeOH in 2% CH3COOH % MeOH in DI H2O % MeOH in 2% NH4OH 140.0 120.0 DSC-18 SPE DSC-8 SPE DSC-CN SPE Recovery (%) 100.0 80.0 60.0 40.0 20.0 0.0 0 5 10 20 40 60 80 100 0 5 10 20 40 60 80 100 0 5 10 20 40 60 80 100 % MeOH

Wash/Elute Profile Neutral Compounds (Fig. E) Because neutral compounds such as hydrocortisone are not ionizable, ph plays a minor role in controlling retention and elution. On C18 and C8 SPE, up to 40% methanol can be used as a potential wash solvent at all ph levels. On CN SPE, 20% methanol is the maximum wash solvent strength before premature elution occurs. 100% methanol is required to fully elute hydrocortisone on C18 and C8 SPE. 80% methanol can be used to elute hydrocortisone on DSC- CN.

Conclusion ph and % organic modifier play a critical role in determining retention and elution of ionizable compounds in reversed-phase SPE. More hydrophobic phases such as C18 have a stronger and broader affinity to a wider range of compounds thus allowing for stronger wash solvents. However, stronger elution solvents may be required to elute compounds of interest. In contrast, less hydrophobic phases such as CN SPE may require weaker wash solvents, but compounds may be eluted using weaker elution solvents. By approaching SPE method development systematically, a greater understanding of analyte behavior relative to changes in extraction conditions is obtained. This allows for more effective method development, optimization, and troubleshooting.